Carl Genberg

Technik-/Wissenschafts-/F&E-Leiter bei Ceragenix Corp.

72 Jahre

Consumer Services

Health Technology

Aktive Positionen von Carl Genberg

Unternehmen	Position	Beginn	Ende
Ceragenix Corp.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2002	-

Unternehmen	Position	Beginn	Ende
N8 Medical, Inc. N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.	Vorstandsvorsitzender	-	01.06.2019
Ceragenix Pharmaceuticals, Inc. Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.	Technik-/Wissenschafts-/F&E-Leiter	01.05.2005	29.03.2010
OnSource Corp.	Corporate Officer/Principal	-	27.06.2005

Cornell University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Consumer Services	3
Health Technology	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	4
OnSource Corp.	Consumer Services
Ceragenix Pharmaceuticals, Inc. Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.	Health Technology
Ceragenix Corp.
N8 Medical, Inc. N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.	Health Technology